In the September 17, 2014, Federal Register, FDA announced it had issued an Emergency Use Authorization for an in vitro diagnostic device to detect of the Ebola Zaire virus (detected in the West Africa outbreak in 2014) at the request of the Department of Defense.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.